Glycogen storage disease type II MRI: Difference between revisions
Irfan Dotani (talk | contribs) (Created page with "__NOTOC__ {{Glycogen storage disease type II}} {{CMG}}; {{AE}} {{PleaseHelp}} ==Overview== ==MRI== ==References== {{reflist|2}} Category:Endocrinology Category:Hepa...") |
No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glycogen storage disease type II}} | {{Glycogen storage disease type II}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Anmol}} | ||
==Overview== | |||
There are no [[MRI]] findings associated with glycogen storage disease type 2 (GSD type 2). However, an [[MRI]] may be helpful in the diagnosis of [[4|neurologic]] complications of GSD type 2, which include central and cortical atrophy. | |||
==MRI== | ==MRI== | ||
*There are no [[MRI]] findings associated with glycogen storage disease type 2 (GSD type 2). However, an [[MRI]] may be helpful in the diagnosis of [[4|neurologic]] complications of GSD type 2, which include:<ref name="pmid12897283">{{cite journal| author=van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT et al.| title=The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. | journal=Pediatrics | year= 2003 | volume= 112 | issue= 2 | pages= 332-40 | pmid=12897283 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12897283 }} </ref> | |||
**Central and cortical atrophy | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Metabolic disorders]] | |||
[[Category:Radiology]] | |||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} |
Latest revision as of 19:42, 23 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II MRI On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II MRI |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
There are no MRI findings associated with glycogen storage disease type 2 (GSD type 2). However, an MRI may be helpful in the diagnosis of neurologic complications of GSD type 2, which include central and cortical atrophy.
MRI
- There are no MRI findings associated with glycogen storage disease type 2 (GSD type 2). However, an MRI may be helpful in the diagnosis of neurologic complications of GSD type 2, which include:[1]
- Central and cortical atrophy
References
- ↑ van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT; et al. (2003). "The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature". Pediatrics. 112 (2): 332–40. PMID 12897283.